Skip to main content
. 2021 Sep 8;11(1):38–43. doi: 10.4103/EUS-D-21-00006

Table 3.

Characteristics of similar studies

Reference Intervention Number of procedure Male Average age Number of technical success Number of clinical success Adverse events Stent patency (days)
Artifon et al. CCD 24 NR Median 68.5 (34-91) 22 17 Bile leakage (1), perforation (1), bleeding (1) NR
HG 25 63.5 (45-91) 24 22 Bacteremia (2), biloma (2), bleeding (1) NR
Khashab et al. CCD 60 32 Mean 62.3 56 48 Peritonitis (1), bile leakage (1), cholangitis (1), bleeding (1), pancreatitis (2), perforation (1), pneumoperitoneum (1) NR
HG 61 38 63.6 56 46 Peritonitis (3), bile leakage (2), cholangitis (2), bleeding (1), intraperitoneal stent (2), sheared wire (1) NR
Ogura et al. CCD 13 8 Mean 71 13 13 Cholangitis (6) Median 43
HG 26 13 70 26 24 Stent occlusion (2) 133
Guo et al. CCD 14 NR NR 14 14 Biliary leakage (1) NR
HG 7 NR NR 7 7 Sepsis (1) NR
Cho et al. CCD 33 13 Median 64 (29-86) 33 33 Pneumoperitoneum (1), bleeding (1), cholangitis (3) Mean 329.1
HG 21 16 66.3 (44-82) 21 18 Pneumoperitoneum (2), abdominal pain (1), bleeding (1) 166.3
Kawakubo et al. CCD 44 21 Median 72 (66-76) 42 41 Bile leakage (3), misplaced stent (1), bleeding (1), pneumoperitoneum (1), perforation (1) Mean 103
HG 20 14 72 (64-81) 19 19 Bile leakage (2), misplaced stent (2), bleeding (1), cholangitis (1), biloma (1) 62

NR: Not reported; CCD: Choledochoduodenostomy; HG: Hepaticogastrostomy